← European Medicine Shortage Tracker · all medicines

Daptomicina shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Daptomicina currently has availability issues reported in 3 European registers: Spain, Greece, Italy.

Shortage  ATC J01XX09 · also listed as: DAPTOMICINA · DAPTOMYCIN · data refreshed 5 November 2026

Key facts

As of 5 November 2026, 3 of the 10 tracked registers list current availability issues for Daptomicina, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2026-05-31 and has now been open for about 6 months. Where agencies state a cause, delivery delays lead with 2 of the 4 stated-cause reports, followed by commercial decisions or discontinuation with 1. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2026-05-31), with Spain following roughly 5 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Greece, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Daptomicina is coded J01XX09 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
DAPTOMICINA DR. REDDYS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial
2026-10-15—Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. Además la Agencia ha autorizado unidades acondicionadas en un
register ↗
🇬🇷 GreeceLimited availability
ZOLBIFEN PD.I.S.INF 350MG/VIAL BTx1 VIALx20 ML
+ 1 more products
ZOLBIFEN PD.I.S.INF 500MG/VIAL BTx1 VIALx20 ML
2026-06-152026-07-27VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητας
Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και
register ↗
🇮🇹 ItalyShortage
CUBICIN
+ 1 more products
DAPTOMICINA DR. REDDY'S
2026-05-31—Cessata commercializzazione definitiva
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2026-05: 12026-06: 22026-07: 02026-08: 02026-09: 02026-10: 12026-052026-10

Full report history (5 register entries)

Every individual register entry for Daptomicina in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITCUBICINShortage2026-12-31—Cessata commercializzazione definitiva
🇪🇸 ESDAPTOMICINA DR. REDDYS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PEShortage2026-10-15—Existen otros medicamentos con el mismo principio activo y m
🇬🇷 GRZOLBIFEN PD.I.S.INF 500MG/VIAL BTx1 VIALx20 MLLimited availability2026-06-262026-07-27VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητ
🇬🇷 GRZOLBIFEN PD.I.S.INF 350MG/VIAL BTx1 VIALx20 MLLimited availability2026-06-152026-07-06VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητ
🇮🇹 ITDAPTOMICINA DR. REDDY'SShortage2026-05-31—Elevata richiesta

Frequently asked

Is Daptomicina currently in shortage in Europe?

Yes. As of 5 November 2026, availability issues are reported in: Spain, Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Daptomicina?

4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Daptomicina availability data come from?

Directly from the official medicines-agency registers that list Daptomicina: AEMPS CIMA (Spain), EOF limited-availability list (Greece), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Daptomicina — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/daptomicina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Daptomicina availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/daptomicina/">Daptomicina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Daptomicina: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.